These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10984293)

  • 1. Growth hormone (GH) replacement therapy: cancer in children receiving GH.
    Shalet SM
    Growth Horm IGF Res; 2000 Apr; 10 Suppl A():S49. PubMed ID: 10984293
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone (GH) replacement therapy: cancer in adults treated with GH.
    Monson JP
    Growth Horm IGF Res; 2000 Apr; 10 Suppl A():S50-1. PubMed ID: 10984294
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth hormone therapy and malignancy.
    Shalet SM; Brennan BM; Reddingius RE
    Horm Res; 1997; 48 Suppl 4():29-32. PubMed ID: 9350443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone treatment and risk of recurrence or progression of brain tumors in children: a review.
    Bogarin R; Steinbok P
    Childs Nerv Syst; 2009 Mar; 25(3):273-9. PubMed ID: 19142625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does growth hormone cause cancer?
    Jenkins PJ; Mukherjee A; Shalet SM
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):115-21. PubMed ID: 16430706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour occurrence and recurrence.
    Ogilvy-Stuart AL; Shalet SM
    Horm Res; 1992; 38 Suppl 1():50-5. PubMed ID: 1295813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
    Gleeson HK; Stoeter R; Ogilvy-Stuart AL; Gattamaneni HR; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3682-9. PubMed ID: 12915655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Hormone Therapy and Brain Tumors.
    Teramoto A
    Pediatr Endocrinol Rev; 2017 Mar; 14 Suppl 1(Suppl 1):229-234. PubMed ID: 28516751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism.
    Arslanian SA; Becker DJ; Lee PA; Drash AL; Foley TP
    Am J Dis Child; 1985 Apr; 139(4):347-50. PubMed ID: 3976624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GH therapy and cancer risk in hypopituitarism: what we know from human studies.
    Pekic S; Popovic V
    Eur J Endocrinol; 2013 Nov; 169(5):R89-97. PubMed ID: 23935131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy for somatopause: risk-benefit analysis and precedents in the treatment of menopause.
    Lamberts SW
    Growth Horm IGF Res; 2000 Apr; 10 Suppl A():S52-3. PubMed ID: 10984295
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.
    Raman S; Grimberg A; Waguespack SG; Miller BS; Sklar CA; Meacham LR; Patterson BC
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2192-203. PubMed ID: 25839904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia.
    Leung W; Rose SR; Zhou Y; Hancock ML; Burstein S; Schriock EA; Lustig R; Danish RK; Evans WE; Hudson MM; Pui CH
    J Clin Oncol; 2002 Jul; 20(13):2959-64. PubMed ID: 12089225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia in growth-hormone-treated patients: an update, 1992.
    Stahnke N
    Horm Res; 1992; 38 Suppl 1():56-62. PubMed ID: 1295814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety profile of GH replacement therapy in adults.
    Chipman JJ; Attanasio AF; Birkett MA; Bates PC; Webb S; Lamberts SW
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):473-81. PubMed ID: 9196611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the impact of recombinant human growth hormone (rhGH) on the plasma lipid profile beneficial or harmful?
    Querfeld U
    Br J Clin Pract Suppl; 1996 Aug; 85():54-5. PubMed ID: 8995033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which children should receive growth hormone treatment. Reserve it for the GH deficient.
    Brook CG
    Arch Dis Child; 2000 Aug; 83(2):176-8. PubMed ID: 10906033
    [No Abstract]   [Full Text] [Related]  

  • 18. Orthopaedic concerns in children with growth hormone therapy.
    Docquier PL; Mousny M; Jouret M; Bastin C; Rombouts JJ
    Acta Orthop Belg; 2004 Aug; 70(4):299-305. PubMed ID: 15481411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone replacement therapy in children with leukemia in remission.
    Taha DR; Bastian W; Castells S
    Clin Pediatr (Phila); 2001 Aug; 40(8):441-5. PubMed ID: 11516051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which children should receive growth hormone treatment. Long term side effects possible with high doses.
    Betts P
    Arch Dis Child; 2000 Aug; 83(2):176-8. PubMed ID: 10950749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.